Seaport Capital has sponsored the merger of content marketing agency Story Worldwide with Byte Interactive, a strategic digital marketing agency. No financial terms were disclosed. www.storyworldwide.com www.byteinteractive.com
The Procter & Gamble Co. (NYSE: PG) has acquired HDS Cosmetics Lab Inc. from North Castle Partners and Easton Capital Group. No financial terms were disclosed. HDS is a Yonkers, N.Y.
TSG Consumer Partners has put Irvine, Calif.-based hair products company PureOlogy Research LLC up for sale, as first reported by The Deal. Barrington Associates is advising TSG on the sale, which could generate between $250 million and $300 million. www.pureology.com
Larry Stevenson has joined Toronto-based private equity firm Callisto Capital as a managing director. He previously was CEO of Pep Boys and, before that, led the Canadian practice of Bain & Company. www.callistocapital.ca
Scott Minick, a managing director with Arch Venture Partners, has been elected chairman of the board for the California Pacific Medical Center. He has been a director on the board since 2003, and is a former executive with both Baxter and Eli Lilly.
Wellington Partners has held a Euro 50 million first close on its third life sciences venture capital fund. Limited partners include EIF, Bear Stearns, Credit Suisse, Merifin Capital, the Messerschmitt Foundation and the National Technology Enterprises Company of Kuwait. A final close on Euro 120 million is scheduled for this summer. www.wellington-partners.com
Achronix Semiconductor Corp., a San Jose, Calif.-based fabless maker of field-programmable gate arrays, has raised $25.4 million in Series A funding. New Science Ventures and Battery Ventures co-led the round, and were joined by Entrepia Ventures and Easton Capital. Larkspur Capital advised Achronix and acted as its placement agent. www.achronix.com
Accuray Inc., a Sunnyvale, Calif.-based developer of a robotic radio-surgery system, has set its proposed IPO terms to 13.33 million common shares being offered at between $14 and $16 per share. It plans to trade on the Nasdaq under ticker symbol ARAY, with JPMorgan and UBS serving as co-lead underwriters. Shareholders include BVI International Investment […]
Synta Pharmaceuticals Corp., a Lexington, Mass.
Optimer Pharmaceuticals Inc., a San Diego-based developer of anti-infective products, has set its proposed IPO terms to 5.25 million common shares being offered at between $12 and $14 per share. It plans to trade on the Nasdaq under ticker symbol OPTR, with Piper Jaffray and Jefferies & Co. serving as co-lead underwriters. It has raised […]